Cardinal Health 2010 Annual Report Download - page 85

Download and view the complete annual report

Please find page 85 of the 2010 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 130

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130

The 4.00%,
5
.
5
0%
5
.6
5
%,
5
.80%,
5
.8
5
%, 6.00% and 6.7
5
% Notes and the Floating Rate Notes due 200
9
r
epresent unsecured obligations. The 7.80% and 7.00% Debentures represent unsecured obligations of Allegiance
Corporation (a wholly-owned subsidiary), which Cardinal Health, Inc. has guaranteed. None of these obligation
s
are subject to a sinking fund and the Allegiance obligations are not redeemable prior to maturity. Interest is paid
p
ursuant to the terms of the obligations. These notes are effectively subordinated to the liabilities of our
subsidiaries, including trade payables of
$
9.5 billion
.
On September 24, 2009, we completed a debt tender announced on August 27, 2009 for an aggregate
p
urchase price, including an early tender premium but excluding accrued interest, fees and expenses, of
$
1.1
billion of the following series of debt securities: (i) 7.80% Debentures due October 1
5
, 2016 of Allegianc
e
Corporation; (ii) our 6.7
5
% Notes due February 1
5
, 2011; (iii) our 6.00% Notes due June 1
5
, 2017; (iv) 7.00
%
Debentures due October 1
5
, 2026 of Allegiance Corporation; (v) our
5
.8
5
% Notes due December 1
5
, 2017
;
(vi) our
5
.80% Notes due October 1
5
, 2016; (vii) our
5
.6
5
% Notes due June 1
5
, 2012; (viii) our
5
.
5
0% Notes du
e
June 1
5
, 2013; and (ix) our 4.00% Notes due June 1
5
, 201
5
. In connection with the debt tender, we incurred a
p
re-tax loss for the early extinguishment of debt of approximately
$
39.9 million, which included an early tender
p
remium of
$
66.4 million, the write-off of
$
5.3 million of unamortized debt issuance costs, and an offsettin
g
$
31.8 million fair value adjustment to the respective debt related to previously terminated interest rate swaps.
T
he debt tender was completed using a portion of the
$
1.4 billion of cash distributed to us from CareFusion in
connection with the S
p
in-Off
.
I
n June 2008, we sold
$
300 million aggregate principal amount of fixed rate notes due 2013 (“the 2013
Notes”) in a registered offering. The 2013 Notes mature on June 1
5
, 2013. Interest on the 2013 Notes accrues a
t
5
.
5
0% per year payable semi-annually. If we experience specific types of change of control and the notes ar
e
r
ated below investment grade by S&P, Moody’s, and Fitch, we will be required to offer to purchase the 2013
Notes at 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to the date of repurchase.
W
e used the proceeds to repay
$
150.0 million of 6.25% Notes due 2008 on July 15, 2008 and to repay
$
149.0
million of
p
referred debt securities on October 3, 2008.
I
n addition to cash and equivalents, at June 30, 2010 and 2009, our sources of liquidity included
a
$
1.5 billion commercial paper program backed by a
$
1.5 billion revolving credit facility. The revolving credi
t
f
acility exists largely to support issuances of commercial paper as well as other short-term borrowings for general
cor
p
orate
p
ur
p
oses and remained unused at June 30, 2010 and 2009, exce
p
t for
$
48.2 million and
$
70.2 million,
r
espectively, of standby letters of credit. On April 1
6
, 2009, in connection with the Spin-Off, we amended ou
r
$
1.5 billion revolving credit facility to, among other things, replace a minimum net worth covenant with
covenants that require us to maintain a consolidated interest coverage ratio as of the end of any fiscal quarter of
at least 4-to-1 and to maintain a consolidated leverage ratio of no more than 3.2
5
-to-1. The new covenants
became effective u
p
on S
p
in-Off. As of June 30, 2010, we were in com
p
liance with these financial covenants.
We also maintain other short-term credit facilities and an unsecured line of credit that allowed fo
r
borrowings up to
$
4.8 million and
$
48.9 million at June 30, 2010 and 2009, respectively. At June 30, 2009
,
$
15.7 million was outstanding under uncommitted facilities, all of which related to CareFusion; there was no
amount outstanding at June 30, 2010. The
$
6.1 million and
$
7.8 million balance of other obligations at June 30
,
2010, and 2009, respectively, consisted primarily of additional notes, loans and capital leases
.
M
aturities of long-term obligations and other short-term borrowings for the next five fiscal years an
d
thereafter are as follows:
(
in millions) 2
0
1
1
2
0
1
2
2013 2
0
14
20
15 Thereafter Total
Maturities of long-term obligations and othe
r
short-term borrowings
.................
$
233.2
$
214.1
$
306.8
$
1.2
$
530.9
$
843.1
$
2,129.3
59